Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
[Delayed]Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31,2025[Under Japanese GAAP]
ZERIA PHARMA, The Current Fiscal Year Ordinary Profit Revised Upward by 9%, Raises Record High Profit Forecast
Summary of Financial Results for the third quarter 2025
[Delayed]Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2025[Under Japanese GAAP]
ZERIA PHARMACEUTICAL CO.,LTD., First Half Ordinary Profit Increases by 45%, July-September Ordinary Profit Increases by 16%
Summary of Financial Results for the second quarter 2025
ZERIA PHARMACEUTICAL CO.,LTD., First Half Ordinary Profit Revised Upward by 42%, Adds to Record High Profit Forecast, Full Year also Increased